almacgroup.com Report : Visit Site

Technical data of the almacgroup.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host almacgroup.com. Currently, hosted in France and its service provider is OVH SAS .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

partnering to advance human health -- about us careers contact us client login search search menu general about about us almac history, culture and values company overview video ethical statement leadership core values & vision our history awards almac awards awards archive sir allen mcclay tax strategy: almac approach our locations careers almac careers careers overview graduate careers experienced professionals economy & cost of living schools, outreach and undergraduates for parents & students for teachers sloane mcclay award uk and row careers us careers applying working at almac why we are different training, learning & development staff recognition health & wellness our locations living in northern ireland overview economy & cost of living education & healthcare almac employee relocation testimonials our exceptional culture our exceptional people our exceptional stories contact us contact us talent network news events knowledge centre knowledge centre overview articles case studies presentations webinars white papers contact us client login client login almac returns waybill generator newsletter signup feedback form company information terms and conditions privacy & cookie policy discovery about us overview meet the team case studies – our people our research research overview ubiquitin specific proteases overview protein-drug conjugates partnerships & collaborations pipeline pipeline overview alm201 wee-1 ubiquitin specific protease platform protein-drug conjugates news & events news events working at almac discovery working at almac discovery contact us contact almac discovery diagnostics go to diagnostics clinical trial solutions our clinical trial solutions biomarker discovery ruo assay development clinical trial assay development cdx development and commercialisation customised cdx clinical testing supporting services regulatory and quality proficiency bioinformatics and biostatistics excellence project management expertise global laboratories our global laboratories platforms & technologies supporting lab services panels and assays dna panel solution rna panel solution assay development pipeline assay development pipeline overview i-o angio ddrd emt prostate dx coldx resources, news & events news upcoming events publications articles posters videos webinars technical sheets almac voice about diagnostics about almac diagnostics meet the team our history the almac group working at diagnostics our culture why almac diagnostics? a day in the life current vacancies contact us contact diagnostics our laboratories api services & chemical development about api services & chemical development api development & manufacture api development and manufacture overview api development and manufacture – early phase api development and manufacture – early phase highly potent manufacture api manufacturing facilities api development and manufacture – late phase api development and manufacture – late phase overview highly potent api manufacture antibody (or protein) drug conjugates (adcs) api manufacturing facilities 14c radiolabelling 14c radiolabelling overview biocatalysis solutions biocatalysis solutions overview: selectazyme™ enzyme panel quotation request enzyme screening biotransformation process development enzyme evolution fermentation development metabolites enzyme screening kits – selectazyme™ peptide & protein technology peptide and protein technology overview custom peptide synthesis for research use custom peptide synthesis for research use overview chemokines & complement proteins human native chemokines human site-specifically biotin labelled chemokines site-specific af647® labelled chemokines modified histones ubiquitylated peptides peptide conjugation gmp peptide manufacture – early phase gmp peptide manufacture – early phase overview reference standard preparation and characterisation physical chemistry studies in support of preformulation development peptide vaccine cocktails highly potent peptide manufacture gmp peptide manufacture – late phase flexyte® fluorescence lifetime technology large scale intermediates arran chemical company pharmaceutical development about about pharmaceutical development pharmaceutical development – early phase pharmaceutical development – early phase overview non-gmp development solubility enhancement potent processing scalability pharmaceutical development – late phase pharmaceutical development – late phase overview quality by design potent processing scalability pharmaceutical drug product development expansion: charnwood facilities charnwood facilities analytical & solid state services analytical & solid state services about analytical & solid state services physical and chemical characterisation method development and validation clinical and commercial analytical support stability testing preformulation preformulation overview pre-clinical package for small molecules formufast™: pre-clinical formulation development enabling salt screen solid state services solid state services overview solid state analysis solid state analysis overview bioclin research laboratories bioclin research laboratories clinical services about about clinical services commercial drug procurement commercial drug procurement overview clinical supply chain management clinical supply chain management overview the physical and digital clinical supply chain technology webez™ pharmacy services blinding of clinical trial supplies overview over-encapsulation inhaler blinding clinical packaging (primary) clinical packaging (primary) overview blistering wallet cards bottling enhanced containment and potent products clinical packaging (secondary) clinical packaging (secondary) overview secondary labelling and kitting of clinical supplies label generation, printing and checking biological products clinical storage & distribution clinical storage & distribution overview distribution global depot network direct-to-patient next gen temperature management overview tempez™ temperature services temperature monitors almac pod™ global distribution qualified person services qualified person services overview qp facilitation program clinical technologies about about clinical technologies interactive response technology (ixrs ® 3) interactive response technology (ixrs ® 3) overview biostatistical consulting reporting data integration clinical integrated services clinical integrated services overview biostatistical services biostatistical services overview art™ – accountability & reconciliation tracking art™ – accountability & reconciliation tracking overview commercial services about about commercial services pharmaceutical product launch & distribution pharmaceutical product launch and distribution overview experience product supply management end-to-end product supply commercial drug product manufacture commercial drug product manufacture overview technology transfer scalability capital projects commercial packaging commercial packaging overview artwork and pack design specialised packaging complex kit assembly pharmaceutical repackaging solutions cbe – 30 filing capital projects dedicated penicillin packaging facilities serialisation serialisation services paediatrics paediatrics commercial storage and distribution commercial storage and distribution overview inventory management & storage import / export support temperature sensitive shipping solutions 3rd party logistics (3pl) menu services general about about us almac history, culture and values company overview video ethical statement leadership core values & vision our history awards almac awards awards archive sir allen mcclay tax strategy: almac approach our locations careers almac careers careers overview graduate careers experienced professionals economy & cost of living schools, outreach and undergraduates for parents & students for teachers sloane mcclay award uk and row careers us careers applying working at almac why we are different training, learning & development staff recognition health & wellness our locations living in northern ireland overview economy & cost of living education & healthcare almac employee relocation testimonials our exceptional culture our exceptional people our exceptional stories contact us contact us talent network news events knowledge centre knowledge centre overview articles case studies presentations webinars white papers contact us client login client login almac returns waybill generator newsletter signup feedback form company information terms and conditions privacy & cookie policy discovery about us overview meet the team case studies – our people our research research overview ubiquitin specific proteases overview protein-drug conjugates partnerships & collaborations pipeline pipeline overview alm201 wee-1 ubiquitin specific protease platform protein-drug conjugates news & events news events working at almac discovery working at almac discovery contact us contact almac discovery diagnostics go to diagnostics clinical trial solutions our clinical trial solutions biomarker discovery ruo assay development clinical trial assay development cdx development and commercialisation customised cdx clinical testing supporting services regulatory and quality proficiency bioinformatics and biostatistics excellence project management expertise global laboratories our global laboratories platforms & technologies supporting lab services panels and assays dna panel solution rna panel solution assay development pipeline assay development pipeline overview i-o angio ddrd emt prostate dx coldx resources, news & events news upcoming events publications articles posters videos webinars technical sheets almac voice about diagnostics about almac diagnostics meet the team our history the almac group working at diagnostics our culture why almac diagnostics? a day in the life current vacancies contact us contact diagnostics our laboratories api services & chemical development about api services & chemical development api development & manufacture api development and manufacture overview api development and manufacture – early phase api development and manufacture – early phase highly potent manufacture api manufacturing facilities api development and manufacture – late phase api development and manufacture – late phase overview highly potent api manufacture antibody (or protein) drug conjugates (adcs) api manufacturing facilities 14c radiolabelling 14c radiolabelling overview biocatalysis solutions biocatalysis solutions overview: selectazyme™ enzyme panel quotation request enzyme screening biotransformation process development enzyme evolution fermentation development metabolites enzyme screening kits – selectazyme™ peptide & protein technology peptide and protein technology overview custom peptide synthesis for research use custom peptide synthesis for research use overview chemokines & complement proteins human native chemokines human site-specifically biotin labelled chemokines site-specific af647® labelled chemokines modified histones ubiquitylated peptides peptide conjugation gmp peptide manufacture – early phase gmp peptide manufacture – early phase overview reference standard preparation and characterisation physical chemistry studies in support of preformulation development peptide vaccine cocktails highly potent peptide manufacture gmp peptide manufacture – late phase flexyte® fluorescence lifetime technology large scale intermediates arran chemical company pharmaceutical development about about pharmaceutical development pharmaceutical development – early phase pharmaceutical development – early phase overview non-gmp development solubility enhancement potent processing scalability pharmaceutical development – late phase pharmaceutical development – late phase overview quality by design potent processing scalability pharmaceutical drug product development expansion: charnwood facilities charnwood facilities analytical & solid state services analytical & solid state services about analytical & solid state services physical and chemical characterisation method development and validation clinical and commercial analytical support stability testing preformulation preformulation overview pre-clinical package for small molecules formufast™: pre-clinical formulation development enabling salt screen solid state services solid state services overview solid state analysis solid state analysis overview bioclin research laboratories bioclin research laboratories clinical services about about clinical services commercial drug procurement commercial drug procurement overview clinical supply chain management clinical supply chain management overview the physical and digital clinical supply chain technology webez™ pharmacy services blinding of clinical trial supplies overview over-encapsulation inhaler blinding clinical packaging (primary) clinical packaging (primary) overview blistering wallet cards bottling enhanced containment and potent products clinical packaging (secondary) clinical packaging (secondary) overview secondary labelling and kitting of clinical supplies label generation, printing and checking biological products clinical storage & distribution clinical storage & distribution overview distribution global depot network direct-to-patient next gen temperature management overview tempez™ temperature services temperature monitors almac pod™ global distribution qualified person services qualified person services overview qp facilitation program clinical technologies about about clinical technologies interactive response technology (ixrs ® 3) interactive response technology (ixrs ® 3) overview biostatistical consulting reporting data integration clinical integrated services clinical integrated services overview biostatistical services biostatistical services overview art™ – accountability & reconciliation tracking art™ – accountability & reconciliation tracking overview commercial services about about commercial services pharmaceutical product launch & distribution pharmaceutical product launch and distribution overview experience product supply management end-to-end product supply commercial drug product manufacture commercial drug product manufacture overview technology transfer scalability capital projects commercial packaging commercial packaging overview artwork and pack design specialised packaging complex kit assembly pharmaceutical repackaging solutions cbe – 30 filing capital projects dedicated penicillin packaging facilities serialisation serialisation services paediatrics paediatrics commercial storage and distribution commercial storage and distribution overview inventory management & storage import / export support temperature sensitive shipping solutions 3rd party logistics (3pl) general about about us company overview video leadership core values & vision our history awards sir allen mcclay our locations careers almac careers careers overview graduate careers experienced professionals schools, outreach and undergraduates for parents & students for teachers sloane mcclay award uk and row careers us careers applying working at almac why we are different training, learning & development staff recognition health & wellness our locations living in northern ireland overview economy & cost of living education & healthcare almac employee relocation testimonials relocation services our exceptional culture our exceptional people our exceptional stories connect with us contact us talent network news events knowledge centre contact us client login x important message like many other companies and institutions around the world, we are experiencing interference with some of our systems within the tnt network. we are implementing remediation steps as quickly as possible. we have implemented operational contingencies to continue to complete collections from customers with scheduled stops. for customers who do not have a regular stop, collection should be arranged via our customer service centers. customers may experience delays in the transit of shipments, particularly inter-continental or non-eu european delivery, as we work to remediate our systems. additionally, if customers do not have the facility for self-labeling, they may also experience delays. we are not able to collect shipments of dangerous goods at this time. we regret any inconvenience to our customers. brexit - a seamless solution timely assurance to you, our client, in relation to brexit negotiations find out more -- watch video upcoming webinar: diagnostic solutions for biomarker-driven clinical trials tuesday 26th june 2018 find out more -- click here to register api & chemical development services high quality, on time and in full delivery of your outsourced projects find out more -- find out more pharmaceutical development expansion new world class facilities to meet your pharmaceutical development and manufacturing needs find out more -- find out more analytical & solid state services comprehensive solutions to support your drug substance and drug product development programs find out more -- find out more upcoming webinar navigating the hidden challenges of clinical packaging and labelling find out more -- click here to register live webinar disrupting the status quo of eclinical identity management: removing the burden at clinical trial sites find out more -- click here to register complimentary workshop: considerations for eu product launch date: 27th june 2018, dublin find out more -- find out more & register recommended resources case study boehringer ingelheim's critical success factor for edc/ irt integration ebook supply chain management for global clinical trials ebook understanding and delivering your eu orphan drug launch white paper ensuring consistency in polymorphic drug substances and products latest news see all news 05 june 2018 brexit – a seamless solution read more 04 june 2018 almac group turnover surpasses £500 million for first… read more 29 may 2018 almac group’s vice president of global business development… read more 04 may 2018 almac group participates in national take our daughters… read more partnering to advance human health explore our locations brexit - a seamless solution timely assurance to you, our client, in relation to brexit negotiations learn more -- pharmaceutical development & manufacturing services almac recognises that you need bespoke solutions to suit your needs. only we can combine the expertise from our world leading range of specialised drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation. find out more diagnostics almac diagnostics is our stratified medicine business unit, specialising in biomarker driven clinical trials. our global laboratories, in the uk and us, offer tailored solutions from discovery to commercialisation: biomarker discovery, assay development & validation, cdx development & commercialisation. your clinical trial diagnostic partner. find out more drug discovery almac discovery is a research driven, oncology business unit within almac dedicated to the discovery and development of novel, innovative approaches to the treatment of cancer. we focus on early stage development and partner programmes with the pharmaceutical industry at the discovery to preclinical stage. find out more upcoming events see all events biomarker and i-o world congress 11 june 2018 boston, ma event info webinar: disrupting the status quo of eclinical identity management: removing the burden at clinical trial sites 14 june 2018 event info clinical trial supply nordics 2018 19 june 2018 copenhagen, denmark event info bos 2018 19 june 2018 basel, switzerland event info stay up-to-date with the latest from almac join our mailing list contact us quick links careers about us our locations latest news knowledge centre almac discovery almac diagnostics privacy policy get in touch european enquiries: +44 (0) 28 3833 2200 north american enquiries: +1 (215) 660 8500 asia pacific enquiries: +65 6309 0720 social links dr steven walker, head of internal product management, will present a webinar on tuesday, june 26 from 11:00am (es… https://t.co/xy0gmw4jko 6 hours ago ©2018 almac group company information terms and conditions privacy & cookie policy this website uses cookies. by continuing to browse the site, you are agreeing to our use of cookies agree this website uses cookies. by continuing to browse the site, you are agreeing to our use of cookies agree

URL analysis for almacgroup.com

https://www.almacgroup.com/diagnostics/clinical-trial-solutions/cdx-development-and-commercialisation/
https://www.almacgroup.com/careers/sloanemcclay/
https://www.almacgroup.com/diagnostics/our-laboratories/
https://www.almacgroup.com/about/
https://www.almacgroup.com/client-login/
https://www.almacgroup.com/client-login/almac-returns-waybill-generator/
https://www.almacgroup.com/presentations/
https://www.almacgroup.com/diagnostics/working-at-almac-diagnostics/a-day-in-the-life/
https://www.almacgroup.com/api-chemical-development/peptide-protein-technology/
https://www.almacgroup.com/diagnostics/portfolio-overview/emt/
https://www.almacgroup.com/careers/staff-recognition/
https://www.almacgroup.com/commercial-services/import-export-support/
https://www.almacgroup.com/tel:
+44
(0)
28
3833
2200
https://www.almacgroup.com/api-chemical-development/reference-standard-preparation-and-characterisation/
https://www.almacgroup.com/about/history-milestones/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: ALMACGROUP.COM
Registry Domain ID: 358754574_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2017-03-05T15:30:55Z
Creation Date: 2006-02-27T05:00:00Z
Registrar Registration Expiration Date: 2020-02-27T05:00:00Z
Registrar: NETWORK SOLUTIONS, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Reseller:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: Almac Sciences
Registrant Organization: Almac Sciences
Registrant Street: 22 Seagoe Industrial Estate
Registrant City: Portadown
Registrant State/Province: County Armagh
Registrant Postal Code: BT63 5QD
Registrant Country: UK
Registrant Phone: +44.2838332200
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Kennedy, John
Admin Organization: Almac Group Ltd
Admin Street: Seagoe Industrial Estate
Admin City: Craigavon
Admin State/Province: Armagh
Admin Postal Code: BT63 5QD
Admin Country: UK
Admin Phone: 4438332200
Admin Phone Ext:
Admin Fax:
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Kennedy, John
Tech Organization: Almac Group Ltd
Tech Street: Seagoe Industrial Estate
Tech City: Craigavon
Tech State/Province: Armagh
Tech Postal Code: BT63 5QD
Tech Country: UK
Tech Phone: 4438332200
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email: [email protected]
Name Server: DNS1.ALMAC-SCIENCES.COM
Name Server: DNS3.ALMAC-SCIENCES.COM
DNSSEC: Unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-07T17:49:18Z <<<


The data in Networksolutions.com's WHOIS database is provided to you by
Networksolutions.com for information purposes only, that is, to assist you in
obtaining information about or related to a domain name registration
record. Networksolutions.com makes this information available "as is," and
does not guarantee its accuracy. By submitting a WHOIS query, you
agree that you will use this data only for lawful purposes and that,
under no circumstances will you use this data to: (1) allow, enable,
or otherwise support the transmission of mass unsolicited, commercial
advertising or solicitations via direct mail, electronic mail, or by
telephone; or (2) enable high volume, automated, electronic processes
that apply to Networksolutions.com (or its systems). The compilation,
repackaging, dissemination or other use of this data is expressly
prohibited without the prior written consent of Networksolutions.com.
Networksolutions.com reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by these terms.

For more information on Whois status codes, please visit
https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.


  REGISTRAR NETWORK SOLUTIONS, LLC.

  REFERRER http://networksolutions.com

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =almacgroup.com

  PORT 43

  SERVER whois.networksolutions.com

  ARGS almacgroup.com

  PORT 43

  TYPE domain

DOMAIN

  NAME almacgroup.com

NSERVER

  DNS1.ALMAC-SCIENCES.COM 212.250.189.61

  DNS3.ALMAC-SCIENCES.COM 12.54.143.25

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

  CHANGED 2016-12-29

  CREATED 2006-02-27

  EXPIRES 2020-02-27

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .